Stockreport

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ [Yahoo! Finance]

Qualigen Therapeutics, Inc.  (QLGN) 
PDF Agreement (the “Agreement”) with Qualigen Therapeutics, Inc. (“Qualigen”) (NASDAQ: QLGN ) to advance the commercialization of Marizyme's first-in-class FDA cleared produ [Read more]